Skip to main content
What types of page to search?

Popular pages: Undergraduate Postgraduate PhD Accommodation Research International students

Alternatively use our A-Z index.
John Field

Professor John Field
MA. PhD, BDS, FRCPath.

Professor of Molecular Oncology (Clinical)
Molecular & Clinical Cancer Medicine
Part of
Institute of Systems, Molecular & Integrative Biology
Faculty of Health and Life Sciences

Contact

J.K.Field@liverpool.ac.uk

.

Professional Activities

External Engagement.

o Co-ordinator for the EU Early Lung Cancer Detection Group. (1997 - 2006 )
o Honorary Consultant Contract at the Liverpool Heart & Chest Hospital, (1997 - )
o UK Forum for Genetics and Insurance Executive Committee (UK FGI) (2000-3)
o Honorary Consultant Contract at the RLBUH Trust, Liverpool (2002 - )
o Co-ordinator for the EU-US Spiral CT Early Lung Cancer Detection Group (2001-06)
o International Lung Cancer Consortium – (ILCCO) Committee (2004 -)
o IASLC Prevention & Early Detection Committee (2005- )
o Chair NCRI Lung Cancer Clinical Studies: Translational subgroup (2005- 2011).
o NCRI Translational Studies CSG Group Committee (2005- 2009)
o PI for the UK Spiral CT Collaborative Screening Trial development team (2005- )
o Chief Investigator of the UK Lung Cancer Screening Trial (UKLS) (2010- )
o Chair IASLC Early Detection and Prevention Committee (2011- )
o Steering Committee International Lung Cancer Consortium (2012- )
o Chair IASLC Task Force – responses to the USA NLST Screening trial (2011) & US Preventive Services Task Force CT Screening recommendations (2013).
o IASLC Tobacco Control Committee (2013-)
o Chair Liverpool Regional Lung Cancer Strategic Alliance Steering Group (2013 -)
o Chair IASLC Strategic Screening Committee, Workshops (2013, 2015, 2016, 2017,2018, 2019).
o IASLC WCLC 2013 – 2019 Programme Committees
o Lung cancer CT Screening Advisory Committee NHS Eng. (2018- )
o NIHR Lung CSG/Early Diagnosis Subgroup (2015- )
o Advisor on Global Committee for ‘Lung Ambition’ (2019- )
o Faculty Chair Institute of Diagnostic Accuracy (iDNA) (2020 - )

Conference Roles

  • dentifying Epidemiological, Clinical and Molecular Markers of Lung Cancer Risk Lung, by Invitation (CHEST-2012 Atlanta , 2012)
  • NCI & European Lung Cancer Screening Trials, by Invitation (Fifth Asia Pacific Perspectives in Lung Cancer-ASIA LUNG , Hong , 2012)
  • 14th National Lung Cancer Symposium Amsterdam , by Invitation (ATS-2012 International Conference San Francisco, USA, 2012)
  • Lung Cancer Screening, by Invitation (14th National Lung Cancer Symposium Amsterdam , 2012)
  • Advances in screening for non-small cell lung cancer., by Invitation (The Royal Marsden Hospital, 2011)
  • Lung Cancer CT Screening trials., by Invitation (AACR, 2011)
  • Progress in risk assessment and early lung cancer screening, by Invitation (Spanish Cancer Research Society -Salamanca , 2011)
  • UKLS: The UK lung Cancer Screening Study., by Invitation (Mesothelioma meeting, Imperial War Museum Duxford, Cambridge, 2011)
  • Lung cancer CT Screening - IASLC Position Statement, Keynote/Plenary by Invitation (IASLC, 2011)
  • Summary of potential screening issues outside clinical trials post NLST press release, by Invitation (International workshop on lung cancer screening randomised trials: state of the art in Europe after the early stop on the, 2011)
  • UKLS, by Invitation (International workshop on lung cancer screening randomised trials: state of the art in Europe after the early stop on the, 2011)
  • The NEXUS between early detection research programmes and the identification of target genetic and e, by Invitation (CURELUNG EU project. Barcelona, 2011)
  • Lung cancer Screening, by Invitation (BTOG 2011 Conference Dublin, 2011)
  • Biomarker Development, by Invitation (IASLC Biomarkers Workshop WCLC – Amsterdam , 2011)
  • Biomarkers in Lung Cancer, by Invitation (IASLC CT Screening Workshop, Amsterdam, 2011)
  • Risk assessment for Lung cancer CT Screening Trial, by Invitation (Arizona State University, Tempe, Arizona, 2010)
  • Liverpool Lung Project & UK Lung Cancer Screening Trial, by Invitation (International Conference Screening Network Biomarkers Workshop Future Opportunity., 2010)
  • Biorepositories: Lessons learned the Liverpool Lung Project repository, by Invitation (Arizona State University, Tempe, Arizona, 2010)
  • Personalization for Early Diagnosis and Treatment: who is at high risk?, by Invitation (Danish Lung cancer , 2010)
  • The Liverpool Lung Project, by Invitation (Cancer Imaging Department of the British Columbia Cancer Research Agency, 2010)
  • Is there a role for lung cancer screening?, by Invitation (BASO - The Association for Cancer Surgery, 2010)
  • selection of the target population for CT screening based on the work of the Liverpool Lung Project, by Invitation (NELSON SYMPOSIUM, 2009)
  • Chair - Lung Cancer Epidemiology and Health Services, by Invitation (IASLC, 2009)
  • Stratification of High Risk Individuals for Early Lung Cancer Detection Screening and Trials, by Invitation (IASLC, 2009)
  • UKLS - UK Lung Cancer Screening, by Invitation (BTOG, 2009)
  • Identification of High Risk individuals in Primary Care, by Invitation (Nottingham PCT, 2008)
  • EU spiral CT Screening Trials Collaborative Position Statement: Intended Collaboration, by Invitation (American Cancer Society, 2008)
  • UK Lung Cancer Screening Trial, by Invitation (IASLC, 2008)
  • Overview of Screening for Lung Cancer, by Invitation (Mick Peake, 2008)
  • British Thoracic Oncology Group Annual Meeting - speaker, by Invitation (British Thoracic Oncology Group, 2008)

Editorships

  • Head and Neck Oncology (Editorial Board Member, 2008 - present)
  • Oncology Reports (Editorial Board Member, 1997 - present)
  • Oral Oncology (Editorial Board Member, 1997 - present)
  • European Journal of Cancer (Editorial Board Member, 1997 - present)
  • International Journal of Oncology (Editorial Board Member, 1997 - present)
  • In Vivo (Editorial Board Member, 1997 - present)

Professional Body Memberships

  • International Association for Dental Research (Member)
  • British Association for Cancer Research (Member)
  • American Association of Cancer Research (Member)
  • Royal College of Pathology (Fellow)
  • British Society for Dental Research (Member)
  • British Society for Human Genetics (Member)
  • British Society of Oral Medicine (Member)
  • International Association for the Study of Lung Cancer (IASLC) (active member, 2000 - present)
  • Human Genome Organisation (active member, 2000 - present)

Other Administrative or Committee Roles

  • Head of the Academic Unit of Maxillofacial Surgery, School of Dentistry (2001-2006)
  • Committees
  • Dental School Research Committee (2002 - 2006),
  • Dental Dean's Advisory Committee (2004-2006)
  • Faculty of Medicine Research Committee (2003-2006)
  • Academic Committee- Senate Reprsenative (2004-2006)
  • Academic Committee Standards Sub Committe (2004-2006)
  • Academic Committee Budget Committee (2004-2006)
  • School of Cancer Studies Exec Committee (2006- 2010 )
  • School of Cancer Studies Research Committee (2006- 2010)
  • School of Cancer Studies Admin Committee (2006- 2010)